SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The community is focused on the rapid and severe collapse of the newly launched meme coin, with many traders labeling the event a definitive rug pull. Debate centers on the speculative nature of politically-themed crypto projects, with participants expressing both frustration over financial losses and cynical reactions toward the coin's association with Hunter Biden.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Air Canada is trending as investors weigh strong travel demand and record bookings against concerns over rising fuel costs and geopolitical tensions impacting the airline industry. Sentiment remains mixed, with bullish focus on share buybacks and fleet expansion, while others are cautious due to volatile fuel prices and broader market uncertainty.

iShares Ethereum Trust (The) - iShares Ethereum Trust ETF

iShares Ethereum Trust ETF

ETHA is trending as traders closely monitor Ethereum's price momentum and relative outperformance compared to Bitcoin. Discussions are centered on the asset's potential for further gains, with some community members debating the benefits of holding the ETF versus staking alternatives or related crypto-equities.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is rallying significantly following a strong quarterly earnings report that featured a revenue and EPS beat alongside a raised full-year outlook. The positive sentiment is further bolstered by management's announcement of a substantial share buyback program and commentary highlighting resilient consumer spending.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

Investors are expressing significant frustration over the stock's persistent decline, with many characterizing the ongoing price weakness as a repetitive pattern that lacks fundamental support or recovery momentum. Sentiment remains deeply divided between those viewing the current valuation as a deep-value buying opportunity due to strong fundamentals and cash positions, and others warning that the stock is a 'value trap' trapped in a long-term downtrend.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, E-Vapor Products and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The E-Vapor Products segment contracts with third-party importers to supply all of its products and sells its e-vapor products to customers in the United States. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group is trending as investors rotate into high-yield, defensive dividend stocks amid broader market volatility and uncertainty. Community discussion highlights the company's long-term value as a 'dividend king' with a strong yield, while interest remains tempered by concerns over declining cigarette volumes and regulatory headwinds.

Subsquid Network is an innovative decentralized data lake and query engine designed to offer developers performant and permissionless access to data, aiming to build a neutral and open internet rooted in Web3 principles. Secured by ZK proofs, the Subsquid network boasts a modular architecture that enables exceptional scalability and developer convenience optimized for blockchain indexing, dApp development, and analytics.  Subsquid is a response to unscalable and rigid monolithic indexing frameworks that had previously gained popularity and market traction among Web3 developers. Today, these frameworks are struggling to adapt in a rapidly evolving blockchain environment. Additionally, the network serves as a highly efficient and decentralized alternative to centralized infrastructure firms, including large RPC and API providers.

The conversation surrounding SQD is primarily centered on its role as decentralized infrastructure for blockchain data indexing, with bullish sentiment driven by its integration with Rezolve AI and partnerships with major enterprise entities. While supporters highlight the token's potential utility and growth in network activity as catalysts for long-term value, skeptics express concerns over price volatility and the nature of its monetization model.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

The KraneShares CSI China Internet ETF is trending due to a wave of bullish sentiment driven by strong Chinese trade data, rising optimism surrounding a potential trade deal or summit with the U.S., and positive technical signals as investors look for a rotation into oversold Chinese tech assets. Many traders are accumulating positions in anticipation of a recovery, though some community members remain skeptical, citing long-term macroeconomic concerns and historical underperformance.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

Investors are expressing significant frustration over recent price volatility and concerns regarding token dilution, while simultaneously reacting to reports of a major institutional investment in the associated exchange. The conversation is characterized by a sharp divide between long-term holders debating the project's long-term viability and participants engaging in speculation about potential catalysts like ETFs and ecosystem growth.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Investors are closely monitoring upcoming earnings and pipeline developments for Harrow Health, with discussions centered on the company's ability to execute its commercial growth strategy and improve revenue transparency. While sentiment is divided between concerns over past guidance misses and optimism regarding long-term potential for its ophthalmic portfolio, many remain focused on the company's ability to demonstrate consistent execution and operational leverage.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ginkgo Bioworks is trending as market participants debate its transition from traditional synthetic biology services to an autonomous, AI-driven laboratory infrastructure play. While supporters emphasize the company's alignment with national strategic initiatives in biosecurity and the potential for long-term scalability, skeptics express significant doubt regarding management's execution, revenue growth, and the sustainability of its business model following multiple pivots.

Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines

Ginkgo Bioworks (NYSE: DNA) today announced that it has been awarded a subcontract for up to $17.5M under the Advanced Research Projects Agency for Healths (ARPA-H) Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program. Ginkgo will serve as a subcontractor to prime...

Ginkgo Bioworks Holdings Enters Oversold Territory (DNA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Palantir's Bold Biosecurity Opportunity Could Be Bigger Than Investors Think

Palantir (NASDAQ: PLTR) and Ginkgo Bioworks (NYSE: DNA) sit on opposite sides of a fast-emerging biosecurity debate. Palantir represents the intelligence layer, while Ginkgo represents the biological infrastructure layer. The question is whether future value comes from identifyin...

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings...

The $59B Quiet Shift Reshaping How Patients Access Care

The $59B Quiet Shift Reshaping How Patients Access Care The $59B Quiet Shift Reshaping How Patients Access Care PR Newswire VANCOUVER, BC, May 12, 2026 Issued on behalf of VentriPoint Diagnostics...

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab Ginkgo Bioworks Reports First Quarter 2026 Financial Results...

Ginkgo Bioworks (NYSE:DNA) Stock Price Up 11.1% - What's Next?

Ginkgo Bioworks (NYSE:DNA) Trading Up 11.1% - What's Next...

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation PR Newswire BOSTON, April 30, 2026 Presentation and Q&A session scheduled for post-market on Thursday, May 7, 2026BOSTON, April 30, 2026 /PRNewswire...

Ginkgo Bioworks (DNA) Projected to Post Quarterly Earnings on Tuesday

Ginkgo Bioworks (NYSE:DNA) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...

Ginkgo Bioworks (NYSE:DNA) Trading 6.9% Higher   - Here's What Happened

Ginkgo Bioworks (NYSE:DNA) Stock Price Up 6.9% - Still a Buy...

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Bearish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$6.75
Prev Close	$6.78
Open	$6.80
Dividend Yield	0.00%
50-Day Moving Average	$7.85
Beta	2.59
Avg. Volume	1.28M
PE Ratio	-1.24

52-Week High	$17.58
52-Week Low	$5.37
Market Capitalization	$454.55M
EPS (Annual)	-$5.64
Price to Book	0.98
Revenue Per Employee	$350,835.05

Feed

News

Sentiment

Earnings

Fundamentals

Info

DNA Fundamentals